DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00760968 (ClinicalTrials.gov)	August 2007	24/9/2008	Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis	A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms in Subjects With Rheumatoid Arthritis	Arthritis, Rheumatoid	Drug: TAK-783 and methotrexate;Drug: Methotrexate	Takeda	NULL	Completed	18 Years	N/A	Both	224	Phase 2	Czech Republic;Latvia;Romania;Russian Federation;Slovakia;Ukraine

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00760968
(ClinicalTrials.gov)

August 2007

24/9/2008

Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms in Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Drug: TAK-783 and methotrexate;Drug: Methotrexate

Takeda

NULL

Completed

18 Years

N/A

Both

224

Phase 2

Czech Republic;Latvia;Romania;Russian Federation;Slovakia;Ukraine